Researchers have designed a potential new treatment for one of the most common forms of muscular dystrophy. Medical researchers have created and tested synthetic DNA-like molecules that interfere with the production of a toxic protein that destroys the muscles of people who have facioscapulohumeral muscular dystrophy (FSHD).